179 related articles for article (PubMed ID: 33562146)
1. An Angiopep2-PAPTP Construct Overcomes the Blood-Brain Barrier. New Perspectives against Brain Tumors.
Parrasia S; Rossa A; Varanita T; Checchetto V; De Lorenzi R; Zoratti M; Paradisi C; Ruzza P; Mattarei A; Szabò I; Biasutto L
Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33562146
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells.
Venturini E; Leanza L; Azzolini M; Kadow S; Mattarei A; Weller M; Tabatabai G; Edwards MJ; Zoratti M; Paradisi C; Szabò I; Gulbins E; Becker KA
Neurosignals; 2017; 25(1):26-38. PubMed ID: 28869943
[TBL] [Abstract][Full Text] [Related]
3. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
Xin H; Sha X; Jiang X; Zhang W; Chen L; Fang X
Biomaterials; 2012 Nov; 33(32):8167-76. PubMed ID: 22889488
[TBL] [Abstract][Full Text] [Related]
4. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma.
Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C
Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333
[TBL] [Abstract][Full Text] [Related]
5. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB.
Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J
ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553
[TBL] [Abstract][Full Text] [Related]
6. DA7R: A 7-Letter Zip Code to Target PDAC.
Parrasia S; Rossa A; Roncaglia N; Mattarei A; Honisch C; Szabò I; Ruzza P; Biasutto L
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242749
[TBL] [Abstract][Full Text] [Related]
7. Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma.
Li Y; Zheng X; Gong M; Zhang J
Oncotarget; 2016 Nov; 7(48):79401-79407. PubMed ID: 27765902
[TBL] [Abstract][Full Text] [Related]
8. A Novel Delivery System of Cyclovirobuxine D for Brain Targeting: Angiopep-Conjugated Polysorbate 80-Coated Liposomes via Intranasal Administration.
Wei H; Liu T; Jiang N; Zhou K; Yang K; Ning W; Yu Y
J Biomed Nanotechnol; 2018 Jul; 14(7):1252-1262. PubMed ID: 29944099
[TBL] [Abstract][Full Text] [Related]
9. Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides.
Zhu Y; Jiang Y; Meng F; Deng C; Cheng R; Zhang J; Feijen J; Zhong Z
J Control Release; 2018 May; 278():1-8. PubMed ID: 29596873
[TBL] [Abstract][Full Text] [Related]
10. Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery.
Gao H; Zhang S; Cao S; Yang Z; Pang Z; Jiang X
Mol Pharm; 2014 Aug; 11(8):2755-63. PubMed ID: 24983928
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.
Wang L; Hao Y; Li H; Zhao Y; Meng D; Li D; Shi J; Zhang H; Zhang Z; Zhang Y
J Drug Target; 2015; 23(9):832-46. PubMed ID: 25856302
[TBL] [Abstract][Full Text] [Related]
12. Novel Mitochondria-Targeted Furocoumarin Derivatives as Possible Anti-Cancer Agents.
Mattarei A; Romio M; Managò A; Zoratti M; Paradisi C; Szabò I; Leanza L; Biasutto L
Front Oncol; 2018; 8():122. PubMed ID: 29740538
[TBL] [Abstract][Full Text] [Related]
13. Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery.
Wei X; Zhan C; Chen X; Hou J; Xie C; Lu W
Mol Pharm; 2014 Oct; 11(10):3261-8. PubMed ID: 24673510
[TBL] [Abstract][Full Text] [Related]
14. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
[TBL] [Abstract][Full Text] [Related]
15. Use of a Noninvasive Brain-Penetrating Peptide-Drug Conjugate Strategy to Improve the Delivery of Opioid Pain Relief Medications to the Brain.
Eiselt É; Otis V; Belleville K; Yang G; Larocque A; Régina A; Demeule M; Sarret P; Gendron L
J Pharmacol Exp Ther; 2020 Jul; 374(1):52-61. PubMed ID: 32327529
[TBL] [Abstract][Full Text] [Related]
16. Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma.
Wang X; Xiong Z; Liu Z; Huang X; Jiang X
Sci Rep; 2018 Aug; 8(1):12827. PubMed ID: 30150691
[TBL] [Abstract][Full Text] [Related]
17. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
[TBL] [Abstract][Full Text] [Related]
18. A novel synergetic targeting strategy for glioma therapy employing borneol combination with angiopep-2-modified, DOX-loaded PAMAM dendrimer.
Han S; Zheng H; Lu Y; Sun Y; Huang A; Fei W; Shi X; Xu X; Li J; Li F
J Drug Target; 2018 Jan; 26(1):86-94. PubMed ID: 28635335
[TBL] [Abstract][Full Text] [Related]
19. Recombinant expressing angiopep-2 fused anti-VEGF single chain Fab (scFab) could cross blood-brain barrier and target glioma.
Ji X; Wang H; Chen Y; Zhou J; Liu Y
AMB Express; 2019 Oct; 9(1):165. PubMed ID: 31617104
[TBL] [Abstract][Full Text] [Related]
20. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
